Statistics

Total Visits

Views
Prospective evaluation of the conversion rate of HER2, ER and PR between primary tumors and corresponding metastases. CONVERTHER/GEICAM 2009-03 study43

Select a period of time:

Number of views in the range

Views
Prospective evaluation of the conversion rate of HER2, ER and PR between primary tumors and corresponding metastases. CONVERTHER/GEICAM 2009-03 study6

Views

Views
June 20250
July 20252
August 20250
September 20252
October 20250
November 20252
December 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States3
Brazil2
Paraguay1
 

Top cities views

Views
Goiânia2
Asunción1
Dallas1